East West Pharma Cardiology portfolio in the spotlight- Thanks to TANCS 2024 Annual conference.
In recent years, East West Pharma’s Cardio-Diabetic Strategic Business Unit (SBU) has experienced remarkable growth, driven by a series of innovative product introductions that align with the evolving needs of patients and clinicians. These advancements have not only strengthened the company’s position in the segment but have also enhanced the relevance of its CD SBU portfolio in addressing the complex demands of cardiovascular and diabetic care.
To further expand its reach and solidify relationships with KOLs, East West Pharma recently participated in the annual conference of the Tamil Nadu Cardiological Society (TANCS), held on 7th & 8th September 2024, at Yercaud. This event provided an ideal platform for the company to showcase its evolved cardio-diabetic portfolio. This event helped the company engage directly with cardiologists and senior physicians. Around 300 delegates, majorly from Tamil Nadu, attended the conference and our stall had a foot fall of 150 delegates. East West Pharma took the initiative to distribute certificate of participation& learning nuggets through its stall which gave additional opportunity to interact with majority of the attendees.
Through participation in such high-profile conferences, East West Pharma continues to demonstrate its commitment to innovation and its focus on addressing the emerging needs, ensuring better outcomes for patients across the cardio-diabetic spectrum.
